Email
weborders@prabadincorp.com
Call us
+1 (786)-332-3938
Home
Blog
Life style
Product Catalog
X
Top News
Pain and Arthritis Products Containing Hidden Ingredients
Painflex Forte may be harmful due to hidden drug ingredients
Max Chemical Inc. – 682037 – 06/20/2024
Cholrem Pty Ltd dba Cholrem and Cholrem Pharmaceuticals – 684036 – 07/09/2024
YangZhou SuXiang Medical Instrument Co., Ltd. – 686655 – 07/08/2024
Optikem International Inc. – 680264 – 06/20/2024
6 Things to Do in Ennis, Texas—From Bluebonnet Trails to a Railroad Museum
ATM Glitch is Causing Chase to Sue Over 1,000 People—Were You Part of It?
She Rescued a Dog on a Mountain—And He Rescued Her Family, Too
April 21 to April 27 Horoscope Forecast: Your Zodiac Sign’s Week
More Money Found: 11 Refunds and Credits You Can Get on Common Expenses
8-Year-Old Makes Easter Baskets for Hundreds of Kids in Need!
China jumpstarts humanoid robot production with EV sector support
Taiwan taps private sector for unmanned naval defense push
CATL to mass-produce first sodium-ion battery by year-end
Foxconn unveils AI-integrated EV, marking major push into global auto market
Tesla’s 2025 slowdown reveals limits of the Musk playbook
Taiwan rides AI wave as US tech orders surge
Drug Test
April 23, 2025
Pain and Arthritis Products Containing Hidden Ingredients
Learn about the warnings for pain and arthritis products that contain hidden drugs and other hidden ingredients.
Drug Test
April 23, 2025
Painflex Forte may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Painflex Forte, a product promoted and sold…
Drug Test
April 23, 2025
Max Chemical Inc. – 682037 – 06/20/2024
CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated
Drug Test
April 23, 2025
Cholrem Pty Ltd dba Cholrem and Cholrem Pharmaceuticals – 684036 – 07/09/2024
Finished Pharmaceuticals/Unapproved New Drugs
Drug Test
April 23, 2025
YangZhou SuXiang Medical Instrument Co., Ltd. – 686655 – 07/08/2024
CGMP/Finished Pharmaceuticals/Adulterated
Drug Test
April 23, 2025
Optikem International Inc. – 680264 – 06/20/2024
CGMP/Finished Pharmaceuticals/Adulterated
Drug Test
April 23, 2025
Laboratorio Magnachem International – 673796 – 06/18/2024
CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated
Drug Test
April 23, 2025
reBom Co., Ltd. – 682811 – 06/26/2024
CGMP/Finished Pharmaceuticals/Adulterated
Drug Test
April 22, 2025
FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products
FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk.
Drug Test
April 22, 2025
Compounding Risk Alerts
FDA issues compounding risk alerts to communicate information to alert health care professionals to adverse events and outbreaks related to…
1
2
3
...
61